Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.1.14 (
SPS
)
813
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The possible presence of a
sucrose-phosphate synthase
(
SPS
) activating/stabilizing factor (SAF) presumably lost during
SPS
purification was investigated. Rice leaf protein extracts were chromatographed in a DEAE-Sephacel column.
SPS
activity of previously purified rice enzyme was enhanced to different extent by aliquots of fractions from such column. The activating capacity could not be replaced by
albumin
, but was nullified by EDTA. When the fractions were boiled or treated with TCA, the activating capacity disappeared suggesting its proteinaceous nature. The presence of 10 microM okadaic acid had no effect on the stimulatory action of SAF on
SPS
denying the possibility to SAF to be a
SPS
-phosphatase. Although it overlaps somehow with sucrose synthase (SS) in DEAE-Sephacel fractions, the activating protein factor and SS eluted separately during Sephadex G-200 chromatography. The activating ability was saturable at a fixed
SPS
concentration and was able to enhance
SPS
activity from other plant sources. Simultaneous studies on the activities of
SPS
and sucrose-phosphate phosphatase (SPP), closely linked to
SPS
, allowed us to suggest that SAF could be SPP. The presence of SAF/SPP did not alter the affinity of
SPS
for its substrates but helped to reverse the Pi inhibition at low Fru-6-P concentrations. We conclude that
SPS
may possibly interact with SPP, contributing to a more effective sucrose synthesis.
...
PMID:Activation of sucrose-phosphate synthase by a protein factor/sucrose-phosphate phosphatase. 883 97
We report on spatial control of nanoporosity in polyelectrolyte multilayer (PEM) films using photopatterning and its effects on film optical and adsorption properties. Multilayers assembled from poly(acrylic acid-ran-vinylbenzyl acrylate) (PAArVBA), a photo-cross-linking polymer, and poly(allylamine hydrochloric acid) (PAH) were patterned using ultraviolet light followed by immersion in low pH and then neutral pH solutions to induce nanoporosity in unexposed regions. Model charged small molecules rhodamine B, fluorescein, and propidium iodide and the model protein
albumin
exhibit increased adsorption to nanoporous regions of patterned PEM films as shown by fluorescence microscopy and radiolabeling experiments. Films assembled with alternating stacks of PAH/poly(sodium-4-styrene sulfonate) (
SPS
), which do not become nanoporous, and stacks of PAH/PAArVBA were patterned to create nanoporous capillary channels. Interdigitated channels demonstrated simultaneous, separate wicking of dimethyl sulfoxide-solvated fluorescein and rhodamine B. In addition, these heterostack structures exhibited patternable Bragg reflectivity of greater than 25% due to refractive index differences between the nanoporous and nonporous stacks. Finally, the PEM assembly process coupled with photo-cross-linking was used to create films with two separate stacked reflective patterns with a doubling in reflectivity where patterns overlapped. The combined adsorptive and reflective properties of these films hold promise for applications in diagnostic arrays and therapeutics delivery.
...
PMID:Photopatterned nanoporosity in polyelectrolyte multilayer films. 1831 57